Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Crystalline Form Iii Of Melanocortin Receptor Agonist Compound And Method For Preparing Same
Abstract: The present invention relates to a crystalline form III of a compound represented by chemical formula 1, a method for preparing same, and a pharmaceutical composition comprising same. The crystalline form III of the compound represented by chemical formula 1 of the present invention can be characterized by an XRD pattern, a DSC profile, and/or a TGA profile.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
29 April 2023
Publication Number
47/2023
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
LG CHEM, LTD.
128, Yeoui-daero
Yeongdeungpo-gu
Seoul 07336
Inventors
1. HAM, Jin Ok
LG Chem Research Park, 188, Munji-ro
Yuseong-gu
Daejeon 34122
2. LEE, Ho Yeon
LG Chem Research Park, 188, Munji-ro
Yuseong-gu
Daejeon 34122
3. KIM, Ji Yoon
LG Chem Research Park, 188, Munji-ro
Yuseong-gu
Daejeon 34122
4. KIM, Sung Won
LG Chem Research Park, 188, Munji-ro
Yuseong-gu
Daejeon 34122
5. CHUN, Seul Ah
LG Chem Research Park, 188, Munji-ro
Yuseong-gu
Daejeon 34122
6. LEE, Sang Dae
LG Chem Research Park, 188, Munji-ro
Yuseong-gu
Daejeon 34122
7. PARK, Jong Won
LG Chem Research Park, 188, Munji-ro
Yuseong-gu
Daejeon 34122
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202317030834-STATEMENT OF UNDERTAKING (FORM 3) [29-04-2023(online)].pdf | 2023-04-29 |
| 2 | 202317030834-REQUEST FOR EXAMINATION (FORM-18) [29-04-2023(online)].pdf | 2023-04-29 |
| 3 | 202317030834-FORM 18 [29-04-2023(online)].pdf | 2023-04-29 |
| 4 | 202317030834-FORM 1 [29-04-2023(online)].pdf | 2023-04-29 |
| 5 | 202317030834-DRAWINGS [29-04-2023(online)].pdf | 2023-04-29 |
| 6 | 202317030834-DECLARATION OF INVENTORSHIP (FORM 5) [29-04-2023(online)].pdf | 2023-04-29 |
| 7 | 202317030834-COMPLETE SPECIFICATION [29-04-2023(online)].pdf | 2023-04-29 |
| 8 | 202317030834.pdf | 2023-05-03 |
| 9 | 202317030834-Proof of Right [31-05-2023(online)].pdf | 2023-05-31 |
| 10 | 202317030834-FORM-26 [19-07-2023(online)].pdf | 2023-07-19 |
| 11 | 202317030834-FORM-26 [27-07-2023(online)].pdf | 2023-07-27 |
| 12 | 202317030834-FORM 3 [04-10-2023(online)].pdf | 2023-10-04 |
| 13 | 202317030834-Certified Copy of Priority Document [10-10-2023(online)].pdf | 2023-10-10 |
| 14 | 202317030834-FER.pdf | 2025-03-03 |
| 15 | 202317030834-Response to office action [12-03-2025(online)].pdf | 2025-03-12 |
| 16 | 202317030834-Others-190325.pdf | 2025-03-21 |
| 17 | 202317030834-Correspondence-190325.pdf | 2025-03-21 |
| 18 | 202317030834-FORM 3 [04-04-2025(online)].pdf | 2025-04-04 |
| 19 | 202317030834-FORM 4 [29-08-2025(online)].pdf | 2025-08-29 |
Search Strategy
| 1 | 202317030834_SearchStrategyNew_E_20230834E_25-02-2025.pdf |